Annual Operating Profit
-$165.53 M
-$4.27 M-2.65%
31 December 2023
Summary:
Kymera Therapeutics annual operaing income is currently -$165.53 million, with the most recent change of -$4.27 million (-2.65%) on 31 December 2023. During the last 3 years, it has fallen by -$119.23 million (-257.49%). KYMR annual operating profit is now -671.67% below its all-time high of -$21.45 million, reached on 31 December 2018.KYMR Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$72.12 M
-$21.20 M-41.63%
30 September 2024
Summary:
Kymera Therapeutics quarterly operating income is currently -$72.12 million, with the most recent change of -$21.20 million (-41.63%) on 30 September 2024. Over the past year, it has dropped by -$14.62 million (-25.41%). KYMR quarterly operating profit is now -792.29% below its all-time high of -$8.08 million, reached on 30 September 2020.KYMR Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$195.27 M
-$14.62 M-8.09%
30 September 2024
Summary:
Kymera Therapeutics TTM operating income is currently -$195.27 million, with the most recent change of -$14.62 million (-8.09%) on 30 September 2024. Over the past year, it has dropped by -$10.42 million (-5.64%). KYMR TTM operating profit is now -1546.29% below its all-time high of -$11.86 million, reached on 30 September 2019.KYMR TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KYMR Operating Profit Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -2.6% | -25.4% | -5.6% |
3 y3 years | -257.5% | -151.9% | -146.2% |
5 y5 years | -671.7% | -508.1% | -1546.3% |
KYMR Operating Profit High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -257.5% | at low | -273.5% | at low | -146.2% | at low |
5 y | 5 years | -671.7% | at low | -792.3% | at low | -1546.3% | at low |
alltime | all time | -671.7% | at low | -792.3% | at low | -1546.3% | at low |
Kymera Therapeutics Operating Profit History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | -$72.12 M(+41.6%) | -$195.27 M(+8.1%) |
June 2024 | - | -$50.92 M(-3.7%) | -$180.65 M(+4.4%) |
Mar 2024 | - | -$52.91 M(+174.0%) | -$173.11 M(+4.6%) |
Dec 2023 | -$165.53 M(+2.7%) | -$19.31 M(-66.4%) | -$165.53 M(-10.5%) |
Sept 2023 | - | -$57.51 M(+32.6%) | -$184.85 M(+7.3%) |
June 2023 | - | -$43.38 M(-4.3%) | -$172.22 M(+1.5%) |
Mar 2023 | - | -$45.33 M(+17.3%) | -$169.65 M(+5.2%) |
Dec 2022 | -$161.26 M(+60.4%) | -$38.63 M(-13.9%) | -$161.25 M(+3.0%) |
Sept 2022 | - | -$44.88 M(+10.0%) | -$156.62 M(+11.6%) |
June 2022 | - | -$40.81 M(+10.5%) | -$140.37 M(+12.9%) |
Mar 2022 | - | -$36.93 M(+8.6%) | -$124.29 M(+23.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2021 | -$100.53 M(+117.1%) | -$33.99 M(+18.7%) | -$100.53 M(+26.7%) |
Sept 2021 | - | -$28.64 M(+15.8%) | -$79.32 M(+35.0%) |
June 2021 | - | -$24.73 M(+87.8%) | -$58.76 M(+21.9%) |
Mar 2021 | - | -$13.17 M(+3.0%) | -$48.23 M(+4.2%) |
Dec 2020 | -$46.30 M(+9.7%) | -$12.78 M(+58.1%) | -$46.30 M(+2.2%) |
Sept 2020 | - | -$8.08 M(-43.0%) | -$45.30 M(-7.7%) |
June 2020 | - | -$14.19 M(+26.2%) | -$49.08 M(+40.7%) |
Mar 2020 | - | -$11.25 M(-4.5%) | -$34.89 M(+47.6%) |
Dec 2019 | -$42.20 M(+96.8%) | -$11.78 M(-0.7%) | -$23.64 M(+99.3%) |
Sept 2019 | - | -$11.86 M | -$11.86 M |
Dec 2018 | -$21.45 M | - | - |
FAQ
- What is Kymera Therapeutics annual operaing income?
- What is the all time high annual operating profit for Kymera Therapeutics?
- What is Kymera Therapeutics annual operating profit year-on-year change?
- What is Kymera Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Kymera Therapeutics?
- What is Kymera Therapeutics quarterly operating profit year-on-year change?
- What is Kymera Therapeutics TTM operating income?
- What is the all time high TTM operating profit for Kymera Therapeutics?
- What is Kymera Therapeutics TTM operating profit year-on-year change?
What is Kymera Therapeutics annual operaing income?
The current annual operating profit of KYMR is -$165.53 M
What is the all time high annual operating profit for Kymera Therapeutics?
Kymera Therapeutics all-time high annual operaing income is -$21.45 M
What is Kymera Therapeutics annual operating profit year-on-year change?
Over the past year, KYMR annual operaing income has changed by -$4.27 M (-2.65%)
What is Kymera Therapeutics quarterly operating income?
The current quarterly operating profit of KYMR is -$72.12 M
What is the all time high quarterly operating profit for Kymera Therapeutics?
Kymera Therapeutics all-time high quarterly operating income is -$8.08 M
What is Kymera Therapeutics quarterly operating profit year-on-year change?
Over the past year, KYMR quarterly operating income has changed by -$14.62 M (-25.41%)
What is Kymera Therapeutics TTM operating income?
The current TTM operating profit of KYMR is -$195.27 M
What is the all time high TTM operating profit for Kymera Therapeutics?
Kymera Therapeutics all-time high TTM operating income is -$11.86 M
What is Kymera Therapeutics TTM operating profit year-on-year change?
Over the past year, KYMR TTM operating income has changed by -$10.42 M (-5.64%)